SCHRODER INVESTMENT MANAGEMENT GROUP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,968,323
-29.5%
96,914
-11.0%
0.00%
-40.0%
Q3 2022$2,793,000
-30.1%
108,950
-32.5%
0.01%
-16.7%
Q2 2022$3,996,000
+26.2%
161,522
+23.4%
0.01%
+50.0%
Q1 2022$3,166,000
+15.4%
130,934
-5.5%
0.00%0.0%
Q4 2021$2,743,000
-2.9%
138,519
-3.5%
0.00%0.0%
Q3 2021$2,824,000
-17.5%
143,509
-7.7%
0.00%0.0%
Q2 2021$3,421,000
+19.5%
155,517
+29.3%
0.00%0.0%
Q1 2021$2,862,000
-79.0%
120,300
-76.9%
0.00%
-60.0%
Q4 2020$13,600,000
+379.2%
519,844
+209.9%
0.01%
+100.0%
Q3 2020$2,838,000
-4.6%
167,746
-5.2%
0.01%0.0%
Q2 2020$2,975,000
+25.6%
176,879
-13.8%
0.01%0.0%
Q1 2020$2,368,000
+996.3%
205,227
+1049.0%
0.01%
Q4 2019$216,000
-10.0%
17,862
+8.6%
0.00%
Q3 2019$240,000
-48.8%
16,453
-44.6%
0.00%
-100.0%
Q2 2018$469,000
-2.3%
29,680
+1.8%
0.00%0.0%
Q1 2018$480,000
-3.2%
29,153
+6.1%
0.00%0.0%
Q4 2017$496,000
+14.8%
27,488
+20.6%
0.00%0.0%
Q3 2017$432,000
+58.8%
22,8000.0%0.00%
Q2 2017$272,00022,8000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders